Press Releases
Summary Global Bioprocessing Trends Report from BioPlan’s 22nd Annual Report and Survey Biomanufacturing is officially out, and the data is clear: the industry is entering a new era of “deliberate transformation.” From major hiring difficulties in process development to the rapid integration of AI in manufacturing, the challenges of 2026 will require a new playbook.
Key Takeaways:
- Cost reduction returns as the SINGLE most important biomanufacturing for industry experts to focus on.
- US-based outsourcing remains at record highs (75% of global intentions), particularly in advanced therapies like cell and gene therapy (82.6%).
Biomanufacturing Initiative and Cancer Moonshot September 2022 19th Annual Press Release [PDF] (2022)
2019 FDA Biopharmaceutical Approvals [PDF] (January 2020)
Advances in Biopharmaceutical Technology in China, 2nd ed [PDF] (October 2018)
15th Annual Report and Survey on Manufacturing [PDF] (September 2018)
13th Annual Report and Survey on Manufacturing – 2016 Trends [PDF] [July 2016]
Biopharmaceutical Expression Systems [PDF] (November 2008)
5th Annual Report Biopharmaceutical Manufacturing [PDF] (April 2008)
Expression Systems Set To Dictate Future of Biopharmaceutical Industry (December 3, 2008)
New Book Demystifies the World of Clinical Trials [PDF] (April 24, 2008)
Advances Biopharmaceutical Technology in China [PDF] (2007)
Biopharmaceutical Manufacturing Capacity to Increase 48% by 2010 According to New Report [PDF] October 2005
Capacity Utilization in Biopharmaceutical Manufacturing Down 8% [PDF] October 2005